Literature DB >> 8149189

Liver damage: mechanisms and management.

D I Sherman1, R Williams.   

Abstract

Despite recent advances in our knowledge of the mechanisms of alcohol-induced liver damage, abstinence from alcohol and supportive measures remain the mainstays of management for the majority of patients. Progress has been made in our understanding of ethanol metabolism, the role of acetaldehyde, and both genetic and environmental factors responsible for the variation in individual susceptibility to alcoholic liver disease. Evidence for the involvement of the immune system and the effects of alcohol on hepatic fibrosis are also reviewed. Recent therapeutic trials of corticosteroids in acute alcoholic hepatitis have confirmed their benefit in patients who have a high risk of mortality. For patients with end-stage cirrhosis, orthotopic liver transplantation is now an accepted therapy in selected patients who have a good prognosis for future abstinence.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8149189     DOI: 10.1093/oxfordjournals.bmb.a072871

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  3 in total

Review 1.  Schiff base forming drugs: mechanisms of immune potentiation and therapeutic potential.

Authors:  H Chen; J Rhodes
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

Review 2.  Advances in alcoholic liver disease: An update on alcoholic hepatitis.

Authors:  Randy Liang; Andy Liu; Ryan B Perumpail; Robert J Wong; Aijaz Ahmed
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 3.  The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanisms.

Authors:  Vali Musazadeh; Arash Karimi; Nasim Bagheri; Jaber Jafarzadeh; Sarvin Sanaie; Mahdi Vajdi; Mozhde Karimi; Hamid Reza Niazkar
Journal:  Biomed Pharmacother       Date:  2022-08-22       Impact factor: 7.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.